ASTCT Pharmacy SIG Journal Club - November 2024

The ASTCT Pharmacy SIG November 2024 Journal Club will air on Wednesday, November 20, 2024 at 2 pm CST/3 pm EST. This webinar consists of two, 30-minute journal club presentations, which include 20 minutes for the presentation and 10 minutes for discussion and a Q&A session. In this Journal Club session, Drs. Kasper and Atkins will present on two articles related to: (a) Axatilimab in recurrent or refractory cGvHD and (b) safety and efficacy of maribavir versus valganciclovir inpatients with CMV post-HCT. This session is intended for pharmacists and other members of the health care team who are involved in managing patients undergoing hematopoietic stem cell transplant or cell therapy.

Presenters & Articles:

Ryan Kasper, PharmD

PGY-2 Pharmacy Resident

University of Pennsylvania

Article: Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

Payton Atkins, PharmD

PGY-2 Pharmacy Resident

University of Kentucky

Article: Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blinded, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir

Session Learning Objectives:

Upon completion of the activity, participants should be able to:

• Summarize current treatment options for chronic graft-versus-host disease (cGVHD) following allogeneic stem cell transplant
• Analyze the safety and efficacy of axatilimab at various doses in patients with relapsed or refractory cGVHD
• Assess the place in therapy of axatilimab based on the data presented in the AGAVE-201 study
• Discuss current standard of care for the management of CMV in patients post-HCT
• Analyze the AURORA trial and associated implications for clinical practice
• Address limitations of the AURORA trial and future research directions for CMV management

ACCREDITED PROVIDER

This activity is jointly provided by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT).

In support of improving patient care, this activity has been planned and implemented by The France Foundation and American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION

Pharmacists

This knowledge-based activity qualifies for 1.0 contact hours (0.10 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

All other healthcare professionals completing this course will be issued a statement of participation.

The full CE information for this session will be available soon.